Fecal Microbiota Transplantation Superior to Fidaxomicin for Recurrent C Difficile Infection
Data from a study presents compelling evidence for the superiority of FMT in multiply recurrent CDI.
All articles by Benjamin Patterson, MBBS
Clinically Important Zoonotic Diseases: Influenza and Salmonella
The One Health Zoonotic Disease Prioritization workshop, organized jointly by the United States CDC, US Department of Agriculture, and US Department for the Interior, recently reported a list of 8 top zoonotic diseases of national concern.
Is a Switch to Oral Antibiotics a Safe Option in Endocarditis?
However, the results of a study titled Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis investigated whether a partial oral regimen may lead to equivalent outcomes.
The Limits of Antimicrobial Sensitivity Testing in Cystic Fibrosis
Management of infection in cystic fibrosis is complex but plays a critical role in improving the survival of those with CF.
Hepatitis E in Industrialized Countries: A Primer for Clinicians
Ribavirin may be effective for HEV, and increased awareness of transmission of HEV is needed in areas that are endemic to the disease.
Whole Genome Sequencing Use in Predicting TB Resistance
Whole genome sequencing of M tuberculosis isolates can identify complete drug susceptibility profiles, allowing precise treatment in early TB infection.
HIV Seroconversion Despite PrEP Therapy
The study evaluated a cohort of 14 young black, men who have sex with men in Atlanta, Georgia, who had HIV seroconversion despite treatment with PrEP.
The Effect of Chronic Pain on HIV Outcomes
Chronic pain is a frequent comorbidity in people living with HIV, with a 2014 systematic review finding a 54% point prevalence.
Piperacillin-Tazobactam for ESBL Bloodstream Infection, Insights From the MERINO Trial
Resistance of gram negative bacteria to some cephalosporins has emerged as a significant threat over the last few decades as a results of ESBL enzymes.
Dolutegravir Use During Pregnancy: What Are the Risks?
Early evidence of a heightened risk for birth defects with dolutegravir is concerning but remains to be fully established.
Next post in HIV/AIDS Advisor
